Michael L. Meyers, SVP, Chief Medical Officer at Syndax Pharmaceuticals Inc (SNDX), bought 8 shares at $4.87 ($39) on 2019-03-21, disclosed to the SEC on 2019-03-25.
Open-market purchase of $39 SNDX by SVP, Chief Medical Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| SNDX | BUY | 2018-11-07 | $958 | — | Filing → |